Does ICATIBANT Cause Therapy non-responder? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Therapy non-responder have been filed in association with ICATIBANT (Icatibant). This represents 0.2% of all adverse event reports for ICATIBANT.
13
Reports of Therapy non-responder with ICATIBANT
0.2%
of all ICATIBANT reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapy non-responder From ICATIBANT?
Of the 13 reports, 2 (15.4%) required hospitalization.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ICATIBANT. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ICATIBANT Cause?
Hereditary angioedema (2,221)
Drug ineffective (506)
Product dose omission issue (421)
Weight decreased (386)
Weight increased (367)
Product use issue (332)
Injection site pain (331)
Inappropriate schedule of product administration (305)
Headache (294)
Malaise (262)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which ICATIBANT Alternatives Have Lower Therapy non-responder Risk?
ICATIBANT vs ICHTHAMMOL\ZINC
ICATIBANT vs ICLUSIG
ICATIBANT vs ICODEXTRIN
ICATIBANT vs ICOSAPENT
ICATIBANT vs ICOSAPENT ETHYL